Medicxi Growth I GP Ltd
CIK 1715600 · last filed 2021-12-02
Medicxi Growth I GP Ltd is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider bought $4.8M of CNTA on Dec 2, 2021. Across all open-market trades the lifetime net is +$47.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $434.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$434.7K
2
3
$47.71M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) Delisted | 10%+ Owner | 236,108 | $40.50 | $9.56M | $7.95M | 2 | 2021-12-02 |
| AURA | 10%+ Owner | 54,065 | $8.04 | $434.7K | $39.76M | 1 | 2021-11-04 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-02 | Centessa Pharmaceuticals plc (CNTA) Delisted | Buy (P) | +388,604 | $4.76M | EDGAR |
| 2021-11-30 | Centessa Pharmaceuticals plc (CNTA) Delisted | Buy (P) | +274,092 | $3.19M | EDGAR |
| 2021-11-04 | AURA | Mixed | +12,159,568 | $39.76M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.